Literature DB >> 21763939

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.

Salim S Abdool Karim1, Angela D M Kashuba, Lise Werner, Quarraisha Abdool Karim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21763939      PMCID： PMC3652579          DOI： 10.1016/S0140-6736(11)60878-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

2.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

3.  Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.

Authors:  Julie B Dumond; Rosa F Yeh; Kristine B Patterson; Amanda H Corbett; Byung Hwa Jung; Naser L Rezk; Arlene S Bridges; Paul W Stewart; Myron S Cohen; Angela D M Kashuba
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

4.  Microbicides & their implications in HIV prevention.

Authors:  Salim S Abdool Karim; Cheryl Baxter
Journal:  Indian J Med Res       Date:  2010-12       Impact factor: 2.375
  4 in total
  123 in total

1.  Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.

Authors:  Albert Y Liu; Nancy A Hessol; Eric Vittinghoff; K Rivet Amico; Elizabeth Kroboth; Jonathan Fuchs; Risha Irvin; R Craig Sineath; Travis Sanchez; Patrick S Sullivan; Susan P Buchbinder
Journal:  AIDS Patient Care STDS       Date:  2014-12       Impact factor: 5.078

Review 2.  Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.

Authors:  Jessica L Adams; Angela D M Kashuba
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-02-04       Impact factor: 5.237

Review 3.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

4.  Colorectal delivery and retention of PEG-Amprenavir-Bac7 nanoconjugates--proof of concept for HIV mucosal pre-exposure prophylaxis.

Authors:  Mahta Samizadeh; Xiaoping Zhang; Simi Gunaseelan; Antoinette G Nelson; Matthew S Palombo; Daniel R Myers; Yashveer Singh; Usha Ganapathi; Zoltan Szekely; Patrick J Sinko
Journal:  Drug Deliv Transl Res       Date:  2016-02       Impact factor: 4.617

Review 5.  Antiretrovirals and safer conception for HIV-serodiscordant couples.

Authors:  Lynn T Matthews; Jennifer A Smit; Susan Cu-Uvin; Deborah Cohan
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

6.  An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.

Authors:  Marc M Baum; Irina Butkyavichene; Scott A Churchman; Gilbert Lopez; Christine S Miller; Thomas J Smith; John A Moss
Journal:  Int J Pharm       Date:  2015-09-16       Impact factor: 5.875

7.  Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.

Authors:  James M Smith; Rachna Rastogi; Ryan S Teller; Priya Srinivasan; Pedro M M Mesquita; Umadevi Nagaraja; Janet M McNicholl; R Michael Hendry; Chuong T Dinh; Amy Martin; Betsy C Herold; Patrick F Kiser
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 8.  Use of antiretrovirals for HIV prevention: what do we know and what don't we know?

Authors:  Jared M Baeten; Robert Grant
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

Review 9.  Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis.

Authors:  Connie Celum; Jared M Baeten
Journal:  Antivir Ther       Date:  2012-12-07

10.  HIV Risk Characteristics Associated with Violence Against Women: A Longitudinal Study Among Women in the United States.

Authors:  Brooke E E Montgomery; Paula M Frew; James P Hughes; Jing Wang; Adaora A Adimora; Danielle F Haley; Irene Kuo; Larissa Jennings; Nabila El-Bassel; Sally L Hodder
Journal:  J Womens Health (Larchmt)       Date:  2018-06-15       Impact factor: 2.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.